NHLBI Emerging Investigator Award (EIA) (R35 Clinical Trial Optional)

The National Institutes of Health (NIH) is seeking applications for the NHLBI Emerging Investigator Award (EIA), which aims to promote scientific productivity and innovation by providing long-term support and increased flexibility to experienced Program Directors/Principal Investigators (PDs/PIs). The award will support a research program, rather than a research project, and will provide the primary and most likely sole source of NHLBI funding on individual grant awards. The EIA will support the research program of NHLBI-funded investigators for up to seven years. Key points to consider: • The EIA is intended to support experienced PDs/PIs who are currently PDs/PIs on at least two NHLBI R01-equivalent awards. • The award will provide investigators with increased freedom to conduct research that breaks new ground or extends previous discoveries in new directions. • The research supported by the EIA must be within the scope of the NHLBI mission. • The award will allow PDs/PIs to take greater risks and to pursue research that requires a longer timeframe.